Monocyte to High-density Lipoprotein Cholesterol Ratio Predicts Poor Outcomes in Ischaemic Heart Failure Patients Combined with Diabetes: a Retrospective Study

Overview

Journal Eur J Med Res

Publisher Biomed Central

Specialty General Medicine

Date 2023 Nov 8

PMID 37941037

Authors

Qiuyu Li

Xiaolong Lin

Xiaowen Bo

Fanqi Li

Siyuan Chen

Xuguang Miao

Donghui Zhao

Jinghua Liu

Qian Fan

Affiliations

Soon will be listed here.

Abstract

Background: The prevalence of ischaemic heart failure (HF) continues to increase. Diabetes mellitus (DM) concomitant with ischaemic HF increases the risk of major adverse cardiovascular events (MACEs). As a promising predictor for cardiovascular diseases, the predictive value of the monocyte to high-density lipoprotein cholesterol ratio (MHR) for MACE in the ischaemic HF with DM cohort has never been investigated before.

Objective: We aimed to investigate the MHR as a predictor for MACE in ischaemic HF patients with DM who underwent percutaneous coronary intervention (PCI).

Methods: This observational study enrolled 1049 patients with ischaemic HF and DM undergoing PCI from June 2017 to June 2019. The baseline data were collected. MACEs, including all-cause mortality, nonfatal myocardial infarction, and any revascularization, were recorded within the 36-month follow-up. The characteristics and incidence of MACE were analysed in four groups stratified by the quartiles of MHR. The hazard ratio for MACE was analysed with Cox regression models. The incidence of MACE in the four groups was evaluated by Kaplan‒Meier survival analysis. Restricted cubic spline analysis was performed to determine the nonlinear correlation between the MHR and MACE.

Results: After the 36-month follow-up, 407 patients (38.8%) experienced MACEs. The incidence of MACE was significantly higher among patients in the upper MHR quartile than among those in the lower MHR quartiles (23.4% vs. 36.0% vs. 41.4% and 54.6%; P < 0.001, respectively), which was consistent with the Kaplan‒Meier survival analyses (P < 0.0001). A multivariate Cox regression model showed that the MHR was an independent risk factor for MACE after variables were adjusted (adjusted HR: 2.11; 95% CI 1.47-3.03; P < 0.001). Its predictive effects on MACE showed no interaction with hypercholesterolemia (P > 0.05).

Conclusion: The MHR was a significant and independent predictor of MACEs in ischaemic HF patients with DM undergoing PCI.

Citing Articles

Prognostic value of remnant-like particle cholesterol in ischemic heart failure patients following percutaneous coronary intervention.

Huang X, Sun T, Zhang B, Ma M, Chen Z, Zhao Z Ann Med. 2025; 57(1):2458200.

PMID: 39898975 PMC: 11792126. DOI: 10.1080/07853890.2025.2458200.

The systemic inflammation response index as a significant predictor of short-term adverse outcomes in acute decompensated heart failure patients: a cohort study from Southern China.

Xie L, Wang Q, Lu H, Kuang M, He S, Xie G Front Endocrinol (Lausanne). 2025; 15:1444663.

PMID: 39764249 PMC: 11700808. DOI: 10.3389/fendo.2024.1444663.

The Monocyte-to-High-Density Lipoprotein Cholesterol Ratio as a Novel Predictor of the Prevalence of Senile Osteoporosis.

Lin N, Li D, Lin S, Ke Y, Lu J, Wu Y Clin Interv Aging. 2024; 19:1773-1788.

PMID: 39502359 PMC: 11537027. DOI: 10.2147/CIA.S478461.

The Associations of Two Novel Inflammation Biomarkers, SIRI and SII, with Mortality Risk in Patients with Chronic Heart Failure.

Zhu D, Wang C, Zhou Y, Che H, Wang R, Cheng L J Inflamm Res. 2024; 17:1255-1264.

PMID: 38415264 PMC: 10898362. DOI: 10.2147/JIR.S451190.

References

Chia Y, Teng T, Chandramouli C, Yap J, Macdonald M, Lam C . Clinical correlates and pharmacological management of Asian patients with concomitant diabetes mellitus and heart failure. Heart Fail Rev. 2018; 23(3):461-468. DOI: 10.1007/s10741-018-9672-5. View

Alfonso F, Byrne R, Rivero F, Kastrati A . Current treatment of in-stent restenosis. J Am Coll Cardiol. 2014; 63(24):2659-73. DOI: 10.1016/j.jacc.2014.02.545. View

Liu Z, Xv Y, Liu X, Zhou X . Associations of systemic inflammatory markers with the risks of chronic heart failure: A case-control study. Clinics (Sao Paulo). 2022; 77:100056. PMC: 9207547. DOI: 10.1016/j.clinsp.2022.100056. View

Cicek G, Kundi H, Bozbay M, Yayla C, Uyarel H . The relationship between admission monocyte HDL-C ratio with short-term and long-term mortality among STEMI patients treated with successful primary PCI. Coron Artery Dis. 2016; 27(3):176-84. DOI: 10.1097/MCA.0000000000000343. View

Wang R, Wu J, Ye H, Zhang X, Wang L . Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF). Medicina (Kaunas). 2022; 58(10). PMC: 9611882. DOI: 10.3390/medicina58101473. View

McAllister D, Read S, Kerssens J, Livingstone S, McGurnaghan S, Jhund P . Incidence of Hospitalization for Heart Failure and Case-Fatality Among 3.25 Million People With and Without Diabetes Mellitus. Circulation. 2018; 138(24):2774-2786. PMC: 6287897. DOI: 10.1161/CIRCULATIONAHA.118.034986. View

Johansson I, Dahlstrom U, Edner M, Nasman P, Ryden L, Norhammar A . Prognostic Implications of Type 2 Diabetes Mellitus in Ischemic and Nonischemic Heart Failure. J Am Coll Cardiol. 2016; 68(13):1404-1416. DOI: 10.1016/j.jacc.2016.06.061. View

Oylumlu M, Oylumlu M, Arik B, Demir M, Ozbek M, Arslan B . Monocyte to high-density lipoprotein cholesterol and lymphocyte to monocyte ratios are predictors of in-hospital and long-term mortality in patients with acute coronary syndrome. Int J Clin Pract. 2020; 75(5):e13973. DOI: 10.1111/ijcp.13973. View

Ganjali S, Gotto Jr A, Ruscica M, Atkin S, Butler A, Banach M . Monocyte-to-HDL-cholesterol ratio as a prognostic marker in cardiovascular diseases. J Cell Physiol. 2018; 233(12):9237-9246. DOI: 10.1002/jcp.27028. View

10.

Volz S, Redfors B, Angeras O, Ioanes D, Odenstedt J, Koul S . Long-term mortality in patients with ischaemic heart failure revascularized with coronary artery bypass grafting or percutaneous coronary intervention: insights from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2021; 42(27):2657-2664. PMC: 8282315. DOI: 10.1093/eurheartj/ehab273. View

11.

Kratofil R, Kubes P, Deniset J . Monocyte Conversion During Inflammation and Injury. Arterioscler Thromb Vasc Biol. 2016; 37(1):35-42. DOI: 10.1161/ATVBAHA.116.308198. View

12.

Sun M, Zhao D, Zhang Y, Zhai Y, Ye M, Wang X . Prognostic Utility of Monocyte to High-Density Lipoprotein Ratio in Patients With Acute Coronary Syndrome: A Meta-Analysis. Am J Med Sci. 2020; 359(5):281-286. DOI: 10.1016/j.amjms.2020.01.018. View

13.

Eyyupkoca F, Yildirim O, Sivri S, Ali-Felekoglu M, Demirtas B, Sait-Altintas M . Admission Monocyte/HDL Ratio Predicts Adverse Cardiac Remodeling After St-Elevation Myocardial Infarction. Rev Invest Clin. 2022; 74(2):104-112. DOI: 10.24875/RIC.21000599. View

14.

Karatas M, Canga Y, Ozcan K, Ipek G, Gungor B, Onuk T . Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2015; 34(2):240-4. DOI: 10.1016/j.ajem.2015.10.049. View

15.

Liu H, Jiang Z, Yang Z, Quan X . Monocyte to high-density lipoprotein ratio predict long-term clinical outcomes in patients with coronary heart disease: A meta-analysis of 9 studies. Medicine (Baltimore). 2022; 101(33):e30109. PMC: 9387949. DOI: 10.1097/MD.0000000000030109. View

16.

From A, Leibson C, Bursi F, Redfield M, Weston S, Jacobsen S . Diabetes in heart failure: prevalence and impact on outcome in the population. Am J Med. 2006; 119(7):591-9. DOI: 10.1016/j.amjmed.2006.05.024. View

17.

Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W . Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2019; 394(10204):1145-1158. PMC: 6891889. DOI: 10.1016/S0140-6736(19)30427-1. View

18.

. [Chinese guideline for percutaneous coronary intervention in patients with left main bifurcation disease]. Zhonghua Xin Xue Guan Bing Za Zhi. 2022; 50(4):349-360. DOI: 10.3760/cma.j.cn112148-20211010-00870. View

19.

Li C, Fan H, Liu Y, Zeng L, Chen P, Duan C . The monocyte to high-density lipoprotein cholesterol ratio and outcomes in type 2 diabetes mellitus patients with non-ST-segment elevation acute coronary syndrome. Ann Transl Med. 2021; 9(21):1627. PMC: 8640916. DOI: 10.21037/atm-21-4876. View

20.

Sercelik A, Besnili A . Increased monocyte to high-density lipoprotein cholesterol ratio is associated with TIMI risk score in patients with ST-segment elevation myocardial infarction. Rev Port Cardiol (Engl Ed). 2018; 37(3):217-223. DOI: 10.1016/j.repc.2017.06.021. View